Novartis Share Price Today | Stock Price & Novartis Share Screener

Track the current stock price of Novartis with an interactive chart. Analyse NOVARTIND share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Novartis stock quote in one place.

The quote of ₹1,967.80 sits between the 52-week low of ₹962.00 and the 52-week high of ₹2,428.20, and the latest session moved 0.14% from the previous close.

Screen Novartis company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NOVARTIND shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE234A01025.

Classification

Identifiers and Leadership

Screen NOVARTIND balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹978, up from ₹948 in 2025.

Latest statistics put total assets at ₹978 and shareholder funds at ₹818, with a leverage ratio of 0.01.

Screen Novartis income statement and profit fundamentals. Analyze NOVARTIND quarterly results. Novartis reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹408 and net profit was ₹98, equal to earnings per unit of ₹39.60, at an operating margin of 27%.

In that period expenses were ₹269, interest cost ₹1 and tax ₹37. The next period listed, 2026-March, shows revenue of ₹393 and net profit of ₹93.

Screen NOVARTIND cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹47.

Over the same period, investing activities provided ₹18 and financing activities used ₹64.

See Novartis shareholding pattern with promoter, FII, and DII holdings. Check Novartis promoter holding and ownership changes for NOVARTIND on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 70.68%, foreign institutions 0.17%, domestic institutions 0.53% and the public 23.25%, spread across 38,116 shareholders.

The shareholder count was 38,116 in 2026-Mar, compared with 36,502 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Novartis. Novartis dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹25.00 per unit for 2026-March, a yield of 1.27%, compared with ₹25.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹25.00, ₹25.00 and ₹25.00 per unit.

See which indices include Novartis stock. Check NOVARTIND index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.

Get Novartis corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Novartis stock events that may affect NOVARTIND share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Annual General Meeting dated September 24, 2026 and Quarterly Result Announcement dated July 23, 2026.

Screen NOVARTIND competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen NOVARTIND latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 3, 2026.

The next most recent announcements are dated October 3, 2026 and October 2, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.